FDA draft guidance calls for long sequencing reads, signalling a major shift toward more complete, standardised safety testing. A single, comprehensive Oxford Nanopore QC test could accelerate the development of safer therapies to the clinic. Learn more: https://bit.ly/3R5lI95

2 likes 0 replies